University home page

Find an ExpertProfiling the University of Melbourne's Researchers

DR ROBIN FILSHIE



Contact Details

Organization: Medicine - St Vincent's Hospital, Clinical School - St Vincent's and Geelong Hospitals
Position: Honorary (Senior Fellow), Honorary (Senior Fellow)
Homepage: www.medstv.unimelb.edu.au
Work: 03 9288 4051
Fax: 03 9288 2581
Level: 02
Building: In Patient Services
Campus: St Vincents Hospital

Government Research Classifications

Research Fields, Courses and Discipline Classifications

Socio-Economic Objective Classifications

Publications

Publications produced at the University of Melbourne and reported in the Annual Publications Collection and 'Research Report' since 2001. The Themis Publications module, released in November 2006, allows additional publications from previous institutions and publications from past years to be entered.

Publications in 2008

Journal Articles

  • Impact of early dose intensity on cytogenetic and molecular responses in chronicphase
    CMLpatients receiving 600 mg/day of imatinib as initial therapy


    Year: 2008
    Journal: Blood
    Volume: 112
    Issue: 10
    Page numbers: 3965-73
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2007

Journal Articles

  • Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-α
    Year: 2007
    Journal: Cancer
    Volume: 110
    Issue: 4
    Page numbers: 801-8
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
  • Measurement of in vivo BCR-ABL kinase inhibition to monitor imatinib-induced target blockade and predict response in chronic myeloid leukemia
    Year: 2007
    Journal: Journal of Clinical Oncology
    Volume: 25
    Issue: 28
    Page numbers: 4445-51
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2004

Journal Articles

  • Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations
    Year: 2004
    Journal: Blood
    Volume: 104
    Page numbers: 2926-2932
    Publisher: American Society of Hematology(Washington DC)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2003

Journal Articles

  • Delayed-onset neutropenia associated with rituximab therapy
    Year: 2003
    Journal: British Journal of Haematology
    Volume: 121
    Page numbers: 913-918
    Publisher: Blackwell Science(Oxford)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.

Publications in 2002

Journal Articles

  • Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation
    Year: 2002
    Journal: American Journal of Transplantation
    Volume: 2
    Issue: 6
    Page numbers: 520-525
    Publisher: Blackwell Munksgaard(Copenhagen)
    Author(s):
    Super Search Source this item in the University's Catalouge locate this resource.
top of page